ERBB2 and ovarian carcinoma: Human epidermal growth factor receptor 2 (HER2) is a tyrosine kinase receptor with a molecular weight of 185 kDa, which is overexpressed in breast cancer, gastric cancer, ovarian cancer, lung cancer and liver cancer (19–23).